Skip to content

Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia

Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia Undergoing Cesarean Section: a Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04556357
Enrollment
138
Registered
2020-09-21
Start date
2020-09-22
Completion date
2021-11-15
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Effect

Keywords

Norepinephrine, Postspinal anesthesia hypotension, Preeclampsia, Cesarean section

Brief summary

The purpose of this study is to investigate the efficacy and safety of norepinephrine for prophylaxis against postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Detailed description

Preeclampsia, which affects 5% to 7% of parturients, is a significant cause of maternal and neonatal morbidity and mortality. Because of constricted myometrial spiral arteries with exaggerated vasomotor responsiveness, though blood pressure in parturients with preeclampsia are apparently higher than healthy parturients, placental hypoperfusion is more common. Spinal anesthesia is still the preferred mode of anesthesia in parturients with preeclampsia for cesarean section. In preeclampsia parturients, spinal anesthesia improve intervillous blood flow (provided that hypotension is avoided) which contribute to increase placental perfusion. Even so, 17-26% parturients with preeclampsia experienced postspinal anesthesia hypotension due to the extensive sympathetic block that occurred with spinal anesthesia. As a potential substitute drug for phenylephrine and ephedrine, norepinephrine has gained traction for use in parturients undergoing cesarean section. But the efficacy and safety in parturients with preeclampsia is still unknown. The purpose of this study is to investigate the efficacy and safety of norepinephrine for prophylaxis against post-spinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Interventions

DRUGPhenylephrine

A maintenance dose of phenylephrine (0.625 μg/kg/min) infusion simultaneous with subarachnoid block

DRUGNorepinephrine

A maintenance dose of norepinephrine (0.05 μg/kg/min) infusion simultaneous with subarachnoid block

Sponsors

General Hospital of Ningxia Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Criteria: Inclusion Criteria: * 18-45 years * Primipara or multipara * Singleton pregnancy ≥32 weeks * American Society of Anesthesiologists physical status classification II to III * Scheduled for cesarean section under spinal anesthesia

Exclusion criteria

* Baseline blood pressure ≥180 mmHg * Body height \< 150 cm * Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2 * Eclampsia or chronic hypertension * Hemoglobin \< 7g/dl * Fetal distress, or known fetal developmental anomaly

Design outcomes

Primary

MeasureTime frameDescription
The incidence of bradycardia1-15 minutes after spinal anesthesia.Heart rate \< 60 beats/min

Secondary

MeasureTime frameDescription
Overall stability of systolic blood pressure control versus baseline1-15 minutes after spinal anesthesiaEvaluated by performance error (PE)

Other

MeasureTime frameDescription
The incidence of severe post-spinal anesthesia hypotension1-15 minutes after spinal anesthesiaSystolic blood pressure (SBP) \< 60% of the baseline
The incidence of nausea and vomiting.1-15 minutes after spinal anesthesiaPresence of nausea and vomiting in patients after spinal anesthesia
The incidence of hypertension1-15 minutes after spinal anesthesiaSystolic blood pressure (SBP) \>120% of the baseline.
Overall stability of heart rate control versus baseline1-15 minutes after spinal anesthesiaEvaluated by performance error (PE)
Partial pressure of oxygenImmediately after deliveryFrom umbilical arterial blood gases.
Base excessImmediately after deliveryFrom umbilical arterial blood gases.
APGAR score1 min after deliveryA= Appearance P=Pulse G=Grimace A=Attitude R=Respiration
pHImmediately after deliveryFrom umbilical arterial blood gases.
The incidence of postspinal anesthesia hypotension1-15 minutes after spinal anesthesiaSystolic blood pressure (SBP) \< 80% of the baseline

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026